logo
Arkansas emergency medicine study at UAMS includes a Pennsylvania university

Arkansas emergency medicine study at UAMS includes a Pennsylvania university

Yahoo27-05-2025
LITTLE ROCK, Ark. – The University of Arkansas for Medical Sciences is partnering with the University of Pittsburgh to study changes in the early treatment of emergency trauma patients.
UAMS officials said the study is to determine if early intervention in patients with traumatic injury with blood loss by using calcium and vasopressin can improve outcomes. They added that the study will include approximately 1,050 people aged 18 to 90 years old.
UAMS receives $1.9 million from Department of Justice to help Little Rock schools with emergency response
Metropolitan Emergency Medical Services (MEMS) will have participating emergency response crews applying the therapy. The therapy can also be applied after a patient arrives at UAMS.
Officials said the trials, labeled CAVALIER for CAlcium and VAsopressin following Injury Early Resuscitation, are a change from the standard procedure of blood transfusions & blood clotting medication and surgery to stop bleeding. UAMS officials said even with these treatments, up to 30% of patients suffering significant blood loss can die.
'We are committed at UAMS to helping improve survival rates of these severely injured patients,' trauma surgeon and the UAMS principal investigator on the study, Dr. Joseph Margolick, said. 'We think early treatment with calcium and vasopressin in trauma patients may improve outcomes.'
Officials said CAVALIER is an Exception from Informed Consent trial, meaning that the trial requires performing a potentially life-saving treatment on people who are too injured to give permission
UAMS launches pilot program for statewide initiative to support mothers, infants after childbirth
The study is supported by a Department of Defense contract and by the UAMS Translational Research Institute.
Copyright 2025 Nexstar Media, Inc. All rights reserved. This material may not be published, broadcast, rewritten, or redistributed.
Orange background

Try Our AI Features

Explore what Daily8 AI can do for you:

Comments

No comments yet...

Related Articles

MCED Tests in Primary Care: Proceed With Caution
MCED Tests in Primary Care: Proceed With Caution

Medscape

time24-07-2025

  • Medscape

MCED Tests in Primary Care: Proceed With Caution

Hi, everyone. I'm Dr Kenny Lin. I am a family physician and associate director of the Lancaster General Hospital Family Medicine Residency, and I blog at Common Sense Family Doctor. Kenneth W. Lin, MD, MPH In the past decade or so that I have been giving lectures on cancer screening at family medicine review courses, not much has changed. We screen for breast, cervical, and colorectal cancer in large numbers of people. We screen for lung cancer in current or past smokers over 50 years of age with at least a 20 pack-year history. We discuss the potential benefits and harms of screening for prostate cancer with older males. But these five cancer types represent a distinct minority of cancers. A 2022 study estimated that only 1 in 7 diagnosed cancer cases in the United States are caught by any of these screening tests, and 57% of cancers have no recommended screening tests, meaning that they are usually not detected until advanced stages. For the past few years, Grail has been selling a blood test that aims to fill the early detection gap by detecting cell-free DNA signals associated with cancer. At $949 per test, the Galleri test is advertised as being able to detect more than 50 cancer types in adults aged 50 years or older. Other companies are developing similar tests. If they haven't already, family physicians will soon be asked to order multicancer early detection (MCED) tests for patients or act on their results. So, what do we know about their benefits and harms? And what remains uncertain? A systematic review published in May 2025 by the Agency for Healthcare Research and Quality found that the evidence for MCED tests consists mostly of diagnostic accuracy studies with suboptimal designs. A few prospective studies have shown that the tests are highly specific but have relatively low sensitivity for early-stage cancers. There is little data on harms such as false alarms, incidental findings, and unnecessary diagnostic procedures and treatments; in one study, patient-reported anxiety associated with a positive MCED result was small and returned to baseline by 12 months, regardless of whether cancer was confirmed. To be effective, MCED tests must accurately detect cancer in asymptomatic people at stages early enough to decrease harm (by subjecting patients to less toxic cancer therapy) or increase benefits (by allowing patients to live longer or better). Already under-resourced primary care practices would need to develop new workflows to work up patients with positive tests and determine when to refer them to oncologists. In a JAMA Internal Medicine Special Communication, screening experts argued that since MCED screening 'would entail tremendous costs and potentially substantial harms", it should not be implemented until a randomized trial reports it reduces all-cause mortality. Others feel that a trial showing fewer cancer-related deaths, such as one being planned by the National Cancer Institute, would be sufficient. An ongoing trial of Galleri in more than 140,000 UK National Health Service patients expects to report effects on cancer stage-shift (a reduction in late stage cancer diagnoses) as early as next year, though it appears to have failed to meet criteria for early indications of benefit. Recognizing that diffusion of MCED tests into practice is outpacing the evidence, the American Cancer Society published a consensus statement to guide primary care clinicians. Important points include communicating uncertainty about benefits and harms, emphasizing that patients with negative results should continue to have all screenings recommended by the US Preventive Services Task Force, and first evaluating patients with positive results for cancer at the predicted tissue of origin (eg, mammography for breast cancer), then ordering total body PET-CT scans if the tissue of origin is unknown or the initial workup is unrevealing.

Pitt will be using an Oakland hotel and off-campus apartments to help house incoming students
Pitt will be using an Oakland hotel and off-campus apartments to help house incoming students

CBS News

time23-07-2025

  • CBS News

Pitt will be using an Oakland hotel and off-campus apartments to help house incoming students

The University of Pittsburgh will be using a hotel in Oakland and some off-campus apartments to help house incoming students this fall. According to a University spokesperson, Pitt is welcoming a record amount of first-year students this fall. With the record number of students soon descending upon Oakland, the University says that housing assignments have been shared with a majority of the incoming class, but some students have been notified that their housing hasn't been determined yet. As a result, the University says it has leased space for more than 400 beds from the Webster Apartments and the Pennsylvania Apartments, both located along North Dithridge Street, and from the Hampton Inn on Hamlet Street. The University says it has also added nearly 300 beds "by leveraging other existing facilities to best meet the needs of our students, including the renovated and recently reopened Franklin Apartments at 305 Atwood Street." All of the off-campus housing assignments, that the University says they expect to be sent to students later this week, are located less than a mile from campus and "meet the University's standards for safety, amenities, and access to campus resources." The University says that students who will be living in the off-campus housing will still have a Resident Assistant and "all other traditional supports one would have in a dorm/residence hall."

Expert outlines grim reality of MRI's dangers after man with 20-pound chain dies in machine mishap: ‘Snap his neck'
Expert outlines grim reality of MRI's dangers after man with 20-pound chain dies in machine mishap: ‘Snap his neck'

New York Post

time22-07-2025

  • New York Post

Expert outlines grim reality of MRI's dangers after man with 20-pound chain dies in machine mishap: ‘Snap his neck'

The Long Island man killed in a freak MRI accident stood no chance against the machine's magnetic field that pulled him in with enough force to 'snap his neck,' according to an expert in the field. A 20-pound chain that Kevin McAllister was wearing around his neck would have been yanked into the machine at Nassau Open MRI with 'hundreds of pounds' of force, Dr. Emanuel Kanal told the Post on Tuesday. 'Even if he was standing there holding the chain in his hands, the strongest weightlifter would not be able to prevent this kind of an accident from happening,' said Kanal, director of Magnetic Resonance Service at the University of Pittsburgh Medical Center. 3 Keith McAllister, 61, suffered multiple heart attacks after he was sucked into an MRI machine by his 20-pound metal chain. Facebook/Karim McAllister 'The problem is it's not a regular magnet, it's not a regular piece of iron. It's an unbelievably powerful magnet, and it's an unbelievably large piece of iron,' Kanal said, adding that the two factors resulted in 'hundreds of pounds of attraction in the direction of the magnet.' McAllister was pinned to the machine for over an hour by the massive exercise chain fitted with a padlock that he wore when he was allegedly led into the machine room by an MRI technician to help his wife who was having her knee examined, his family said. When he got 'within a few inches' of the machine, it could suddenly pull with 'such strength that it could have pulled sufficiently strongly to snap his neck,' Kanal said. 3 Family of McAllister claimed the 61-year-old was led into the machine room by a technician who did not tell the doting husband to remove his large metal chain. Brigitte Stelzer McAllister was pronounced dead at North Shore University Hospital the day after the bizarre accident with the cause being identified as three heart attacks, according to his family. '[D]epending on the status of his health, he may have had problems with cardiovascular disease before, and when the excitement happened, he could have had a heart attack just from the event itself,' Kanal stated. McAllister's wife described the haunting moments when her husband was breathing his last. 'His body went limp,' Adrienne Jones-McAllister told News 12 Long Island. 'He went limp in my arms and this is still pulsating in my brain,' she told the outlet through tears. Despite decades in the medical industry, Kanal said the bizarre manner of death is incredibly rare. 3 The MRI machine could have pulled McAllister with enough force to snap his neck, an expert told The Post. Brigitte Stelzer '[It's] extremely rare that someone dies because of an interaction with a strong magnetic field — probably fewer than a dozen times since MRI first became a diagnostic tool in the early 1980s,' the expert stated. His stepdaughter claimed the technician never warmed McAllister to take off the necklace that led to his demise. 'While my mother was laying on the table, the technician left the room to get her husband to help her off the table,' step-daughter Adrienne Jones-McAllister wrote in a GoFundMe. 'He forgot to inform him to take the chain he was wearing from around his neck off when the magnet sucked him in,' she wrote.

DOWNLOAD THE APP

Get Started Now: Download the App

Ready to dive into a world of global content with local flavor? Download Daily8 app today from your preferred app store and start exploring.
app-storeplay-store